These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 12460045

  • 21. Maintaining patency of tunneled hemodialysis catheters--efficacy of aspirin compared to warfarin.
    Obialo CI, Conner AC, Lebon LF.
    Scand J Urol Nephrol; 2003; 37(2):172-6. PubMed ID: 12745728
    [Abstract] [Full Text] [Related]

  • 22. Secondary autogenous arteriovenous fistulas in the "fistula first" era: results of a longterm prospective study.
    Salman L, Alex M, Unger SW, Contreras G, Lenz O, Asif A.
    J Am Coll Surg; 2009 Jul; 209(1):100-5. PubMed ID: 19651069
    [Abstract] [Full Text] [Related]

  • 23. A single center experience in the use of polyurethaneurea arteriovenous grafts.
    Jefic D, Reddy PP, Flynn LM, Provenzano R.
    Nephrol News Issues; 2005 Jul; 19(8):44-7. PubMed ID: 16104342
    [Abstract] [Full Text] [Related]

  • 24. Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis.
    Pisoni RL, Arrington CJ, Albert JM, Ethier J, Kimata N, Krishnan M, Rayner HC, Saito A, Sands JJ, Saran R, Gillespie B, Wolfe RA, Port FK.
    Am J Kidney Dis; 2009 Mar; 53(3):475-91. PubMed ID: 19150158
    [Abstract] [Full Text] [Related]

  • 25. Effect of route of EPO administration on hemodialysis arteriovenous vascular access failure: a randomized controlled trial.
    Lee YK, Koo JR, Kim JK, Park II, Joo MH, Yoon JW, Noh JW, Vaziri ND.
    Am J Kidney Dis; 2009 May; 53(5):815-22. PubMed ID: 19324483
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effect of demographic characteristics and timing of vascular access maturation on patency in Chinese incident haemodialysis patients.
    Ng YY, Wu SC, Hung YN, Ko PJ.
    Nephrol Dial Transplant; 2009 Nov; 24(11):3447-53. PubMed ID: 19506047
    [Abstract] [Full Text] [Related]

  • 34. Outcome and complications of permanent hemodialysis vascular access in Nigerians: a single centre experience.
    Alhassan SU, Adamu B, Abdu A, Aji SA.
    Ann Afr Med; 2013 Nov; 12(2):127-30. PubMed ID: 23713021
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Association of low serum fetuin A levels with poor arteriovenous access patency in patients undergoing maintenance hemodialysis.
    Chen HY, Chiu YL, Chuang YF, Hsu SP, Pai MF, Lai CF, Yang JY, Peng YS, Tsai TJ, Wu KD.
    Am J Kidney Dis; 2010 Oct; 56(4):720-7. PubMed ID: 20801568
    [Abstract] [Full Text] [Related]

  • 37. Survival of vascular access during daily and three times a week hemodialysis.
    Quintaliani G, Buoncristiani U, Fagugli R, Kuluiranu H, Ciao G, Rondini L, Lowenthal DT, Reboldi G.
    Clin Nephrol; 2000 May; 53(5):372-7. PubMed ID: 11305810
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.